MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$516,474K
(-7337.70%↓ Y/Y)
(benefit) provision for
income taxes
-$47,028K
(-316.43%↓ Y/Y)
Neurosurgery
$827,667K
(2.97%↑ Y/Y)
Instruments
$206,472K
(1.12%↑ Y/Y)
ENT
$166,372K
(22.65%↑ Y/Y)
Regenerative Skin And Wound
$323,488K
(-7.72%↓ Y/Y)
Private Label
$111,246K
(-4.37%↓ Y/Y)
(loss) income before
income taxes
-$563,502K
(-2989.88%↓ Y/Y)
Interest income
$18,474K
(-7.81%↓ Y/Y)
Codman Specialty
Surgical
$1,200,511K
(4.97%↑ Y/Y)
Tissue Technologies
$434,734K
(-6.89%↓ Y/Y)
Operating (loss) income
-$493,370K
(-1836.55%↓ Y/Y)
Interest expense
$86,255K
(22.12%↑ Y/Y)
Total revenue, net
$1,635,245K
(1.53%↑ Y/Y)
Other (expense)
income, net
-$2,351K
(-159.61%↓ Y/Y)
Total costs and
expenses
$2,128,615K
(34.54%↑ Y/Y)
Cost of goods sold
$803,625K
(10.32%↑ Y/Y)
Selling, general and
administrative
$699,700K
(-2.41%↓ Y/Y)
Goodwill impairment
charge
$511,365K
Research and development
$98,971K
(-14.22%↓ Y/Y)
Intangible asset
amortization
$14,954K
(-29.76%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)